Cocrystal Pharma Inc (COCP)
2.20
+0.43
(+24.29%)
USD |
NASDAQ |
Nov 14, 16:00
2.03
-0.17
(-7.73%)
After-Hours: 20:00
Cocrystal Pharma Free Cash Flow (Quarterly): -3.699M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.699M |
| March 31, 2024 | -4.511M |
| December 31, 2023 | -3.385M |
| September 30, 2023 | -2.681M |
| June 30, 2023 | -5.562M |
| March 31, 2023 | -3.156M |
| December 31, 2022 | -4.905M |
| September 30, 2022 | -8.97M |
| June 30, 2022 | -3.724M |
| March 31, 2022 | -3.91M |
| December 31, 2021 | -2.93M |
| September 30, 2021 | -5.407M |
| June 30, 2021 | -2.639M |
| March 31, 2021 | -1.795M |
| December 31, 2020 | -2.382M |
| September 30, 2020 | -3.08M |
| June 30, 2020 | -2.327M |
| March 31, 2020 | -2.281M |
| December 31, 2019 | -1.231M |
| September 30, 2019 | -1.438M |
| June 30, 2019 | -1.032M |
| March 31, 2019 | 1.993M |
| December 31, 2018 | -1.985M |
| September 30, 2018 | -2.157M |
| June 30, 2018 | -2.093M |
| Date | Value |
|---|---|
| March 31, 2018 | -2.083M |
| December 31, 2017 | -1.58M |
| September 30, 2017 | -2.186M |
| June 30, 2017 | -1.092M |
| March 31, 2017 | -2.085M |
| December 31, 2016 | -2.303M |
| September 30, 2016 | -3.159M |
| June 30, 2016 | -5.184M |
| March 31, 2016 | -4.06M |
| December 31, 2015 | -3.162M |
| September 30, 2015 | -3.386M |
| June 30, 2015 | -2.544M |
| March 31, 2015 | -1.564M |
| December 31, 2014 | -1.756M |
| September 30, 2014 | -1.143M |
| June 30, 2014 | -1.338M |
| March 31, 2014 | -1.78M |
| December 31, 2013 | -0.811M |
| September 30, 2013 | -0.949M |
| June 30, 2013 | -0.978M |
| March 31, 2013 | -0.952M |
| December 31, 2012 | 0.2159M |
| September 30, 2012 | 0.3587M |
| June 30, 2012 | -0.1375M |
| March 31, 2012 | -2.178M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.97M
Minimum
Sep 2022
-1.231M
Maximum
Dec 2019
-3.609M
Average
-3.156M
Median
Mar 2023
Free Cash Flow (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -9.917M |
| Alaunos Therapeutics Inc | -1.681M |
| Oragenics Inc | -1.544M |
| Cara Therapeutics Inc | -12.65M |
| Jaguar Health Inc | -8.186M |